SCHEMBL7888643

SCHEMBL7888643

C=CCOC(=O)N1C[C@@H](SC(C)=O)C[C@H]1Cc1csc2cncn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7895220 0.86
SCHEMBL7891384 0.84 SIGMAR1 (0.30)
SCHEMBL7883663 0.84 IDO1 (0.31)
SCHEMBL7883357 0.82 IDO1 (0.31)
SCHEMBL7883471 0.82 IDO1 (0.31)
SCHEMBL7890612 0.82
SCHEMBL7883171 0.81
SCHEMBL7883170 0.81
SCHEMBL8557065 0.81
SCHEMBL7890559 0.81 ECE1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180622-B1 ANTIMICROBIAL ACTIVITY AGAINST A WIDE RANGE OF BACTERIA INCLUDING GRAM-POSITIVE BACTERIA, GRAM-NEGATIVE BACTERIA, BETA-LACTAMASE-PRODUCING BACTERIA, RESISTANT PSEUDOMONAS AERUGINOSA,METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND MEIJI SEIKA KAISHA, LTD. (JP) 2001-01-30 US disclosed
EP-0887352-A1 CARBAPENEM DERIVATIVES AND ANTIMICROBIALS MEIJI SEIKA KAISHA LTD. (JP) 1998-12-30 EP disclosed